Bone marrow cancer
MONDO:0021138Malignant neoplasms that either originate from the bone marrow (e.g. myeloid leukemias) or involve the bone marrow as secondary-metastatic tumors (e.g. metastatic carcinomas to the bone marrow). --2003
Also known as: bone marrow cancer, cancer of bone marrow, malignant bone marrow neoplasm, malignant bone marrow tumor, malignant bone marrow tumour, malignant neoplasm of bone marrow
4426 clinical trials for this condition and its sub-types, 2 tagged with Bone marrow cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bone marrow cancer
-
Myeloproliferative neoplasm 166 trials · 1,632 incl. sub-types
13 sub-types
- Myeloid leukemia 30 trials · 1,334 incl. sub-types Sub-types →
- Myelodysplastic/myeloproliferative neoplasm 81 trials · 234 incl. sub-types Sub-types →
- Primary myelofibrosis 191 trials · 195 incl. sub-types Sub-types →
- Myelofibrosis 149 trials
- Erythroid neoplasm 0 trials · 95 incl. sub-types Sub-types →
- Essential thrombocythemia 67 trials
- Therapy-related myeloid neoplasm 54 trials
- Myeloproliferative neoplasm, unclassifiable 11 trials · 16 incl. sub-types Sub-types →
- Transient myeloproliferative syndrome 13 trials
- Chronic neutrophilic leukemia 10 trials
- Chronic eosinophilic leukemia 9 trials
- Myeloproliferative disease, autosomal recessive 0 trials
- Thrombocytopenia 6 0 trials
Most studied deeper sub-types
-
New hope for rare bone cancer: targeted drug added to chemo in major trial
Disease control OngoingThis study tests whether adding a targeted drug called ganitumab to standard chemotherapy helps people with newly diagnosed Ewing sarcoma that has spread. The trial includes 312 participants and aims to see if the combination improves survival without the cancer growing back. The…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Patients choose: transplant or Non-Transplant for rare bone marrow cancer?
Disease control OngoingThis study looks at two treatment options for people with a high-risk form of myelofibrosis, a rare bone marrow cancer. Participants choose whether they want a stem cell transplant or the best non-transplant treatments available. Researchers then track survival and quality of lif…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC